Approaches

Learn About Clinician Approaches to Tobacco Cessation on Webcast Series

by
OSU Wexner Medical Center logo

Learn About Clinician Approaches to Tobacco Cessation on Webcast Series.  Participants will gain an understanding of evidence-based strategies to support patients in quitting tobacco including behavioral interventions and pharmacotherapy options. Actuarily, on average, a woman who smokes a pack of cigarettes a day will live 11 years less than a woman who doesn’t smoke. Men who smoke a pack a day live 12 years less than non-smoking men. If you do the math, that works out to 14 minutes of life lost for every cigarette a person smokes. It’s a childhood epidemic with 90% of smokers beginning before age 18. By the time they are adults, they are fully addicted and quitting becomes very hard because of the severity of nicotine withdrawal symptoms.   But the good news is that we can help ameliorate those symptoms to help patients quit their nicotine habits.

Joining us today are two of the Ohio State University’s tobacco cessation experts. Lindsey Lee is a clinical pharmacist in the Division of General Internal Medicine. And Suzanne Higginbotham is also a clinical pharmacist in the Division of General Internal Medicine.

What you’ll learn in this webcast

As a result of this educational activity, webcast participants will be able to:

  • Understand the health impacts of tobacco use
  • Apply evidence-based cessation strategies and interventions for nicotine dependence
  • Implement appropriate treatment and follow up protocols to enhance patient adherence and reduce relapse

You’ll also learn about the following:

  • Nicotine dependence tests
  • The pharmacist’s role in tobacco cessation
  • Nicotine replacement strategies for the heavy smoker
  • Cytisinicline (cytisine)
  • Pharmacologic approach to inpatients who are smokers
  • Pharmacologic approach to the smoker with coronary artery disease
  • Tobacco cessation and adolescents
  • Weight gain and tobacco cessation
  • E-cigarettes and tobacco cessation
  • Cough increase in the short-term after smoking cessation
  • Tobacco cessation in the habitual marijuana smoker
  • Over the counter pharmacologic therapies
  • Pharmacist prescriptive authority

You can find this and many other MedNet21 programs on the OSU – CCME website.

Call our MedNet21 Program Manager at 614.293.3473 for more details about subscribing to MedNet21 as a hospital or as an individual.  You can also e-mail him at derrick.freeman@osumc.edu.

Learn About Clinical Approaches to Cannabis Use

by
OSU Wexner Medical Center logo

Learn About Clinical Approaches to Cannabis Use on webcast.  As of this recording in October 2024, Cannabis is legal for medical use in 38 states, 4 US territories and the District of Columbia and it’s legal for recreational use in 24 states, 3 territories and DC. For the upcoming 2024 election cycle, cannabis is on the ballot for 4 additional states. And earlier this year, the Drug Enforcement Administration proposed moving cannabis from its current Schedule I drug classification to a Schedule III classification. The hearing for that move is scheduled for the end of 2024.

With cannabis becoming more and more accessible, cannabis use is becoming more and more commonplace. As physicians, it has become vital to know how to assess a patient’s cannabis use and treat patients with risky or unhealthy cannabis use. For this topic, We’ve invited one of Ohio State University’s Behavioral Health experts. I am pleased to introduce Assistant Professor of Psychiatry and Behavioral Health, Dr. David Weiss. David is a psychologist who the relationship between studies stress and immune response.

What you’ll learn in this webcast

As a result of this educational activity, webcast participants will be able to:

  • Increase ability to distinguish between disordered cannabis use, hazardous use, and medical use.
  • Improve skills to increase patient engagement in cannabis cessation or reduction treatment.

You’ll also learn about the following:

  • Cannabis Terminology
  • Medical Use
  • THC vs CBD
  • Screening

You can find this and many other MedNet21 programs on the OSU – CCME website.

Call our MedNet21 Program Manager at 614.293.3473 for more details about subscribing to MedNet21 as a hospital or as an individual.  You can also e-mail him at derrick.freeman@osumc.edu.

CME Webcast Teaches on Emerging Approaches in Parkinson’s Disease

by
OSU Wexner Medical Center logo

CME Webcast Teaches on Emerging Approaches in Parkinson’s Disease. There is no cure for Parkinson’s disease. Yet, there is reason for hope. In recent years, groundbreaking research has propelled us closer to understanding the underlying mechanisms of the condition and developing more effective treatments. From deep brain stimulation to innovative pharmacological interventions, the future of Parkinson’s care is brighter than ever before.

To discuss the new developments in Parkinson’s Disease care, we’ve have invited an expert from Ohio State University Wexner Medical Center’s Center for Parkinson’s Disease. We are pleased to introduce Assistant Professor of Neurology Dr. Zachary Jordan. Zach is fellowship trained in movement disorders and specializes in the care of Parkinson’s Disease.

What you’ll learn in this webcast

As a result of this educational activity, webcast participants will be able to:

  • Understand the basic approach to medical management of motor symptoms in Parkinson’s disease
  • Recognize motor complications and the strategies that exist to address them

You’ll also learn about the following:

  • Prevalence
  • Prognosis
  • Dosing
  • Adjuvant Therapies
  • Advance Care Planning
  • Treatment Side Effects
  • Cognitive Dysfunction
You can find this and many other MedNet21 programs on the OSU – CCME website.

Call our MedNet21 Program Manager at 614.293.3473 for more details about subscribing to MedNet21 as a hospital or as an individual.  You can also e-mail him at derrick.freeman@osumc.edu.

Learn about Insomnia on On-line CME Webcast

by

OSUWexnerbloglogo2014 Learn about Insomnia on On-line CME Webcast. For many people, insomnia is a nightly occurrence, leading to nocturnal frustration and daytime fatigue. On this CME webcast, we’re going to explore insomnia, what causes it and what you can advise your patients to do about it. Our guests today are specialists in sleep medicine. Dr. Meena Khan is an Assistant Professor of Internal Medicine and of Neurology, and Dr. Jesse Mindel, who is an Assistant Professor of Neurology.

View a video introduction of this webcast

What you’ll learn in this webcast

As a result of this educational activity, webcast participants will be able to: REVIEW basic approaches to insomnia treatment; REVIEW available behavioral and pharmacologic therapies for insomnia; Describe the epidemiology and health implications of chronic insomnia; DESCRIBE the psychological characteristic of those with chronic insomnia; and DESCRIBE the behavioral and environmental factors that perpetuate chronic insomnia.

You’ll also learn about the following:

  • Common causes of insomnia
  • Normal sleep patterns
  • Melatonin
  • Sleep binging
  • Circadian rhythm disturbances
  • Eye patches and background noise recordings
  • Antihistamines
  • Approach to the patient who wakes up and cannot fall back to sleep
  • Approach to temporary situational insomnia

You can find this and many other MedNet21 programs on the OSU – CCME website.
Call our MedNet21 Program Manager at 614.293.3473 for more details about subscribing to MedNet21 as a hospital or as an individual. You can also e-mail him at derrick.freeman@osumc.edu.